Integrative Analysis of Large-cell Lung Cancer

Recruiting now

Conditions studied: Lung Cancer

In brief

Integrative analysis of LCLC

Key facts

Study ID

NCT02917369

Run by

Shanghai 10th People's Hospital

People needed

1000

Starts

2016-01-01

Expected to finish

2026-12-01

Last updated by the study team

2016-09-28

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≤ 75 years with histologically proven LCLC
• No severe major organ dysfunction
• World Health Organization (WHO) performance status of 0 or 1
• No prior cancer chemotherapy

You may not qualify if…

• Age ≥ 76
• Severe major organ dysfunction
• WHO performance status of >1
• Prior cancer chemotherapy

Where it is running

• Ganzhou City People's Hospital — Ganzhou, Jiangxi, China (enrolling)
• Shanghai Tenth People's Hospital — Shanghai, Shanghai Municipality, China (enrolling)
• Shanghai Pulmonary Hospital — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.